Alectinib(CH5424802)
Catalog No: 51907
CAS Number: 1256580-46-7
Purity: 98.5%
Alectinib is a second-generation, orally active, potent and highly selective inhibitor of anaplastic lymphoma kinase (ALK). Alectinib is approved for the treatment of ALK fusion-gene positive, unresectable, advanced or recurrent non-small cell lung cancer (NSCLC) in Japan, where it has been given orphan drug designation.
For research use only. We do not sell to patients.
Chemical Information
| Name | Alectinib(CH5424802) |
|---|---|
| Iupac Chemical Name | 9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
| Synonyms | Alectinib;CH5424802;CH-5424802;CH 5424802 |
| Molecular Formula | C30H34N4O2 |
| Molecular Weight | 482.62 |
| Smile | C(C)C1=CC2=C(C(C=3NC4=CC(=CC=C4C3C2=O)C#N)(C)C)C=C1N1CCC(CC1)N1CCOCC1 |
| InChiKey | KDGFLJKFZUIJMX-UHFFFAOYSA-N |
| InChi | InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3 |
| CAS Number | 1256580-46-7 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 98.5% |
| Storage | 3 years -20ºCpowder |
| Solubility | 2mg/ml in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature. |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
-cas-1256580-46-7.png)